All Comments by
- Elizabeth Head on Oligomeric amyloid-beta peptide disrupts phosphatidylinositol-4,5-bisphosphate metabolism.
- Lary Walker on Participation in dementia research: rates and correlates of capacity to give informed consent.
- Michael G. Agadjanyan on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
- Akihiko Nunomura on Immunotherapy: Old Dogs, New Tricks
- Elizabeth Head on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
- Davide Tampellini on Keystone Drug News: Glimpse of Lilly’s Phase 1 Passive Vaccine
- Anusuyadevi Jayachandran on Persistence of (Worm) Memory Depends on Calsyntenin/Alcadein Ortholog
- Tommaso Russo on Neurogenesis Gets a Jolt From Enhanced APP Processing, Curcumin
- Ralph Nixon on Novel targets for Huntington's disease in an mTOR-independent autophagy pathway.
- Brigita Urbanc on Affibodies—Putting the β in Aβ?
- Kumar Sambamurti on Keystone Drug News: CoMentis BACE Inhibitor Debuts
- Dave Morgan on A two-year study with fibrillar beta-amyloid (Abeta) immunization in aged canines: effects on cognitive function and brain Abeta.
- Gregory Cole on Neurogenesis Gets a Jolt From Enhanced APP Processing, Curcumin
- Mike Malek-Ahmadi on Alzheimer Activism: How To Modernize Clinical Trials?
- Virgil Muresan on New Role for p25/Cdk5 in Regulation of BACE Expression